Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
EVOQ Remedies Ltd. currently stands out as a deep value pick due to its extremely low valuation metrics compared to its peers, despite lacking revenue and profitability. The company's high PE ratio alongside no ROE and other profitability metrics indicates underlying challenges, yet its low market cap presents potential for recovery if operational metrics improve.
Strong revenue growth (12.56% YoY) and solid ROE (17.12%), making it a leader in profitability.
High EPS growth and solid ROE, with a reasonable PE and strong market cap.
Excellent ROE (49.14%) but very high PE, indicating potential overvaluation despite high profitability.